With a yield of 4.2% and 10 years of 21% dividend hikes under its belt, I’ve got my eye on this cheap UK stock for my passive income portfolio.

ALMOST 40 jobs are promised as a laboratory testing company expands its operations with a centre at York Biotech Campus.

IBBQ is a relatively new US biotech ETF that competes with established peers like IBB and XBI. Read why I don't recommend ...

The Venerable Galboda Siri Gnanissara Memorial Scholarship Trust Fund was officially inaugurated on September 19 at the ...

ALMOST 40 jobs are promised as a laboratory testing company expands its operations with a centre at York Biotech Campus.

Bangalore (Karnataka) [India], September 21: Australia's La Trobe University and the Bangalore Bioinnovation Centre (BBC) based in the Indian state of Karnataka will establish a Bio Innovation ...

Chief Minister N. Chandrababu Naidu expressed his profound gratitude to Suchitra Ella, Managing Director of Bharath Biotech, ...

Another biotech startup revealed plans Friday evening for an initial public offering, making it the sixth startup to list new ...

As retail investors flock to Viking Therapeutics, the biotech firm is also catching the eye of billionaire fund managers like ...

We recently published a list of 10 Worst Booming Stocks to Buy According to Short Sellers. In this article, we are going to ...

Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and ...

Vivek Ramaswamy accused the media of focusing on pet-eating Haitian migrants conspiracy instead of migration influx issues in ...